Cg Oncology Inc Revenue per Employee (CGON), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cg Oncology Inc   (NASDAQ: CGON)
 

Cg Oncology Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Cg Oncology Inc 's Revenue per employee fell on a trailing twelve month basis to $ 43,423, but the productivity of Cg Oncology Inc 's employees remained above the company average.
Within the Healthcare sector Cg Oncology Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Cg Oncology Inc has 142 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CGON Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change -3.72 % - 1982.69 % 409.21 % 3774.42 %
Sales per Employee (TTM) $ 43,423 43,859 35,711 28,451 15,310
CGON's Total Ranking # # # # # 3871
Seq. Revenue Change 38.63 % 6.83 % -53.36 % 39.38 % -

CGON Company Profile >> Back to CGON Efficiency Comparisons >> Compare CGON Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 43,859 $ 18,847 $ 4,662
(Jun 30 2026)   (Mar 31 2025)



Financial Statements
Cg Oncology Inc 's Revenue MRQ $ 2 Millions Visit CGON's Income Statement
Cg Oncology Inc 's Revenues TTM $ 6 Millions Visit CGON's aggregate revenue growth
What are CGON's Sales? Visit CGON's Sales by Segment




Other Ratios
Cg Oncology Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CGON's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CGON's Competitors
Revenue per Employee for CGON's Suppliers
Revenue per Employee for CGON's Customers

You may also want to know
CGON's Sales Growth Rates CGON's Pe Price to earnings ratio CGON's Receivables Turnover Ratio CGON's Stock Quote
CGON's Net Income Growth Rates CGON's Ps Price to Sales ratio CGON's Sales per Employee CGON's Asset Turnover Ratio
CGON's Net Margin CGON's Pb Price to Book ratio CGON's Financial Strength Ratios CGON's Dividend Payout Ratio
Date modified: 2026-11-09T18:44:47+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Healthcare Services Group Inc   52,218.33 $ 1,879.860  Million 36,000 
Dbv Technologies S a   22,611.76 $ 3.844  Million 170 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.